Upload File

glp-1 receptor agonists in primary care: what is their place?

  • Home
  • Documents
  • GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
33
GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Upload: lucian-rodgers

Post on 31-Dec-2015

15 views

Category:

Documents


0 download

Report

Tags:

DESCRIPTION

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?. Program Goals. ADA/EASD 2012 Recommendations. DURATION 2: Change in HbA 1c at 26 Weeks. DURATION 2: Change in Body Weight at 26 Weeks. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Page 2: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 3: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Program Goals

Page 4: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 5: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

ADA/EASD 2012 Recommendations

Page 6: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 7: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 8: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 9: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 10: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 11: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 12: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 13: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 14: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

DURATION 2: Change in HbA1c at 26 Weeks

Page 15: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

DURATION 2: Change in Body Weight at 26 Weeks

Page 16: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 17: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 18: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 19: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 20: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 21: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 22: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 23: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 24: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 25: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 26: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 27: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 28: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 29: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 30: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 31: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 32: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?
Page 33: GLP-1 Receptor Agonists in Primary Care: What Is Their Place?

Type 2 Diabetes Treatment: Novel Therapies GLP-1 Receptor Agonists/Analogs and DPP-4 Inhibitors

GLP-1 RECEPTOR AGONISTS - FLAME · 2019. 4. 21. · OBJECTIVES u To understand the mechanism of action of GLP -1 Receptor Agonists u To counsel the patient regarding the benefits,

CP.CPA.16 Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists...GLP-1 receptor agonists are indicated as adjunct to diet and exercise to improve glycemic control with type 2 diabetes

Revised Clean TXT submitted to Expert Review of Clinical ... Clean What'… · GLP-1 receptor agonists (GLP-1RAs) (see below section 6) appear to reduce CV risk by different mechanisms,

Session 10: Drugs GLP-1 receptor agonists...GLP-1ra different effects based on the duration of their action in the receptor Exenatide BID Lixisenatide Dulaglutide Exenatide LAR Albiglutide

GLP-1 Agonists and Dipeptidyl Peptidase 4

Topical Administration of GLP-1 Receptor Agonists Prevents ...(a GLP-1 receptor [GLP-1R] agonist) prevent electroretino-graphy(ERG) abnormalities and morphological featuresrelated

Differential properties of GLP-receptor agonists: The … · (Marcus Aurelius AD 121-180) ... • intubation/aspiration! Gastric emptying! ... Protocol! Umapathysivam et al, Diabetes

Deprescribing benzodiazepine receptor agonists (BZRAs

CHAPTER 4 4.pdf · We hypothesised that GLP-1 receptor agonists reduce food intake by affecting brain areas regulating appetite and reward, and that these effects are GLP-1 receptor

Toll-Like Receptor–2/6 and Toll-Like Receptor–9 Agonists ...€¦ · Toll-like receptor (TLR) 2/6 and 9 agonists attenuated para-influenza virus in the lung. TLR agonists failed

Chapter 19 Adrenoceptor agonists §1. , receptor agonists §2. receptor agonists §3. receptor agonists

1 GLP-1 Receptor Agonists: Emerging Treatments in Diabetes Therapeutics Shannon I. Brow, RN, CDE, FNP-C Medical Science Liaison Amylin Pharmaceuticals,

Adrenergic Receptor Agonists

GLP-1 Receptor Agonists for the Management of Type 2 ... · GLP-1 Receptor Agonists for the Management of Type 2 Diabetes: ... Exenatide April 2005 5-mcg and 10-mcg pens SC Twice

Scientific Exchange: Perioperative considerations for New ... · GLP-1 Receptor Agonists Summary GLP-1 RA increase glucose-dependent insulin secretion, reduces glucagon, increase

Oral Small Molecule GLP-1 Receptor (GLP-1R) Agonists for

GLP-1 receptor agonists reduce liver inflammation in a 3 ...€¦ · Glucagon-like peptide 1 (GLP-1) receptor agonists are characterized with anti-inflammatory capacity suitable to

GLP-1 Physiology and Evolving Clinical Data on GLP-1 Receptor … · 2020-05-18 · GLP‐1 Physiology and Evolving Clinical Data on GLP‐1 Receptor Agonists for the Management of

Develop Novel Muscarinic Receptor Agonists

Different Serotonin Receptor Agonists Have Distinct ... serotonin receptor agonists have...few studies examining the physiological roles of different serotonin receptor types in this

GLP-1 Receptor Agonists: How Early Is Appropriate?

Updates on GLP-1 Receptor Agonists: Improving Adherence in Type 2 Diabetes

(2008) Targeting Incretins in Type 2 Diabetes. Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors

WHY WE DO, WHAT WE DO · 2019-12-04 · Injectable class Mechanism Advantages Disadvantages GLP-1 receptor agonists •Activates GLP-1 receptor • Insulin, glucagon secretion •Slows

SGLT-2 inhibitors and GLP-1 receptor agonists for … · 2019-07-19 · GLP-1 receptor agonists are able t o reduce cardiovascular events and all-cause mortality, as well as progression

Bydureon ® (exenatide once-weekly) Scientific slides: GLP-1 receptor agonists and the discovery of exenatide GLP-1, glucagon-like peptide-1. Developed

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class

PIONEER 1: Randomized Clinical - Diabetes Care · 2019. 11. 11. · Glucagon-likepeptide1(GLP-1)receptor agonists are effective treatment options forachievingglycemiccontrolinpatients

Are all GLP-1 Analogs Created equal · Not all GLP-1 receptor agonists are the same GLP-1 receptor agonists can be classified in several ways Structure: GLP-1-based Exendin-4-based

GLP-1 receptor agonists in the treatment of Type 2 · PDF fileGLP-1 receptor agonists in the treatment of Typeff2 diabetes Review future science group 403 fatty acid is slightly longer

Topical Administration of GLP-1 Receptor Agonists Prevents … · 2015-12-16 · GLP-1R expression has been found in retinas from rats (19) and chickens (20), and in ARPE-19 cells

Effects of GLP-1 receptor agonists and SGLT-2 inhibitors

GLP-1 Receptor Agonists Dr. Aronson has received …icdm2013.diabetes.or.kr/slide/OT3-3 Ronnie Aronson.pdf · GlaxoSmithKline, Takeda, Novartis, AstraZeneca, Boehringer Ingelheim,

Diabetes Management with GLP-1 Receptor Agonists